Sumitomo Mitsui Ds Asset Management Company, LTD Ionis Pharmaceuticals Inc Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

  • $9.15 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021
SELL
$34.54 - $47.25 $250,449 - $342,609
-7,251 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$46.85 - $61.05 $702 - $915
15 Added 0.21%
7,251 $427,000
Q1 2020

Apr 21, 2020
BUY
$41.6 - $63.4 $2,246 - $3,423
54 Added 0.75%
7,236 $342,000
Q3 2019

Oct 16, 2019
BUY
$59.06 - $72.15 $64,906 - $79,292
1,099 Added 18.07%
7,182 $430,000
Q2 2019

Aug 13, 2019
BUY
$62.09 - $86.14 $377,693 - $523,989
6,083 New
6,083 $390,000

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.79B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email